Koninklijke Philips NV ADR
$ 29.09
0.00%
15 Apr - close price
- Market Cap 27,369,159,000 USD
- Current Price $ 29.09
- High / Low $ 29.30 / 28.98
- Stock P/E 26.19
- Book Value 13.50
- EPS 1.09
- Next Earning Report 2026-05-05
- Dividend Per Share $0.85
- Dividend Yield 3.55 %
- Next Dividend Date 2026-06-03
- ROA 0.03 %
- ROE 0.08 %
- 52 Week High 33.44
- 52 Week Low 21.95
About
Koninklijke Philips NV is a healthcare technology company in North America, Greater China and internationally. The company is headquartered in Amsterdam, the Netherlands.
Analyst Target Price
$33.74
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-10 | 2025-11-04 | 2025-07-28 | 2025-04-28 | 2025-02-19 | 2024-10-28 | 2024-07-29 | 2024-04-29 | 2024-01-29 | 2023-10-23 | 2023-07-24 | 2023-04-24 |
| Reported EPS | 0.7141 | 0.36 | 0.2846 | 0.2832 | 0.51 | 0.32 | 0.3 | 0.26 | 0.41 | 0.33 | 0.28 | 0.22 |
| Estimated EPS | 0.5365 | 0.3697 | 0.3174 | 0.1449 | 0.6 | 0.35 | 0.25 | 0.26 | 0.57 | 0.32 | 0.3 | 0.14 |
| Surprise | 0.1776 | -0.0097 | -0.0328 | 0.1383 | -0.09 | -0.03 | 0.05 | 0 | -0.16 | 0.01 | -0.02 | 0.08 |
| Surprise Percentage | 33.1034% | -2.6237% | -10.334% | 95.4451% | -15% | -8.5714% | 20% | 0% | -28.0702% | 3.125% | -6.6667% | 57.1429% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-05 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.23 |
| Currency | USD |
Previous Dividend Records
| Jun 2026 | Jun 2025 | Jun 2022 | Jun 2021 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-06-03 | 2025-06-06 | 2022-06-08 | 2021-06-09 | None | None | None | None | None | None |
| Amount | $1.01303 | $0.88604 | $0.964112 | $1.033107 | $0.960117 | $0.991704 | $0.762926 | $0.766224 | $0.759016 | $0.925548 |
Next Dividend Records
| Dividend per share (year): | $0.85 |
| Dividend Yield | 3.55% |
| Next Dividend Date | 2026-06-03 |
| Ex-Dividend Date | 2026-05-13 |
Recent News: PHG
2026-04-15 10:29:41
Koninklijke Philips is prioritizing growth in diagnostics, image-guided therapy, and AI-driven health solutions, moving beyond consumer electronics to focus on connected care ecosystems. The company's strategy aligns with rising healthcare spending driven by demographics and technological adoption, with a strong emphasis on integrating AI algorithms for improved patient outcomes and operational efficiency. Philips aims for mid-single-digit comparable sales growth and strong operating margins, backed by significant R&D investments and a commitment to shareholder returns.
2026-04-15 04:40:45
Koninklijke Philips N.V. has strategically shifted its focus to health technology, emphasizing connected diagnostics and patient monitoring, which aligns well with U.S. healthcare spending priorities. This transformation positions the company to capitalize on booming healthcare trends, providing investors with exposure to resilient growth without significant domestic risks. Despite potential litigation and supply chain risks, Philips' R&D investments and integrated platforms offer strong competitive advantages and long-term value in the digital health sector.
2026-04-14 14:41:00
Koninklijke Philips (ADR) stock (NL0000009538) continues to prioritize its healthcare technology segment, driven by high-growth areas like medical imaging and patient monitoring. The company's strategic shift from consumer electronics to a pure-play health tech leader, coupled with its software integration, positions it well in a market where healthcare spending is set to exceed $6 trillion by 2030 in the U.S. alone. Despite facing regulatory and supply chain risks, Philips' focus on innovation, strong financial health, and expansion into ambulatory care offer a compelling risk-reward for investors seeking defensive growth.
2026-04-14 14:40:45
Koninklijke Philips (ADR) (PHG) is strategically prioritizing healthcare technology, focusing on medical imaging, patient monitoring, and health informatics, to capitalize on the growing demand from aging populations and digital health adoption. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments, with innovations like AI-enhanced imaging driving recurring service revenue and competitive differentiation against rivals like GE HealthCare and Siemens Healthineers. Despite regulatory and supply chain risks, Philips maintains a solid financial position and is expanding into ambulatory care, positioning itself for long-term growth and appealing to investors seeking defensive growth strategies.
2026-04-14 07:40:45
This article provides financial information for Koninklijke Philips N.V. (HAM:PHI1), specifically focusing on its revenue per share. It appears to be a stub or data-focused page from TradingView, displaying basic financial details like period, value, and change metrics for the company.
2026-04-13 21:39:05
Koninklijke Philips N.V. (NL0000009538) is refocusing on high-margin health technology segments like diagnostics and monitoring, especially in the US market, which is experiencing rising healthcare spending and an aging population. The company's pivot towards interconnected health ecosystems and digital solutions, moving away from consumer appliances, positions it for steady growth and increased investor appeal. While facing risks from ongoing litigation and competition, Philips' R&D investment and strong North American presence underscore its potential for scalable growth and predictable cash flows.
